The Minnesota Partnership for Biotechnology & Medical Genomics has awarded $775,577 to Peter Dosa, Associate Program Director in the Institute for Therapeutics Discovery & Development, for his project "Novel Therapeutic Agents for the Treatment of Glaucoma." Michael Fautsch of the Mayo Clinic will collaborate on the project.